Not applicableStudy completedNCT03073239What this trial is testingAmyotrophic Lateral Sclerosis: a New ParadigmWho this might be right forAmyotrophic Lateral Sclerosis Conde, Bebiana, M.D. 30
Not applicableStudy completedNCT01948102What this trial is testingIdentification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose SamplesWho this might be right forAmyotrophic Lateral Sclerosis Wake Forest University Health Sciences 132
Not applicableUnknownNCT05951556What this trial is testingTelehealth Implementation of Brain-Computer InterfaceWho this might be right forAmyotrophic Lateral SclerosisStroke Shirley Ryan AbilityLab 7
Not applicableNot Yet RecruitingNCT07606235What this trial is testingTranscutaneous Superior Laryngeal Nerve Stimulation to Upregulate Swallowing Frequency and Urge to Swallow in Patients Living With ALSWho this might be right forAmyotrophic Lateral Sclerosis (ALS)DysphagiaDystussia Nova Southeastern University 5
Not applicableLooking for participantsNCT05204017What this trial is testingComprehensive Analysis Platform To Understand, Remedy and Eliminate ALSWho this might be right forAmyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy+1 more University of Alberta 150
Early research (Phase 1)Active Not RecruitingNCT06493279What this trial is testingEvaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral SclerosisWho this might be right forAmyotrophic Lateral Sclerosis Als RJK Biopharma Ltd 9
Not applicableStudy completedNCT02418546What this trial is testingElectronic-health Application To Measure Outcomes REmotely Clinical TrialWho this might be right forNeurodegenerative DiseaseWeight LossAmyotrophic Lateral Sclerosis+3 more Massachusetts General Hospital 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT06365216What this trial is testingALS Phase II Study of NX210cWho this might be right forAmyotrophic Lateral Sclerosis Axoltis Pharma 80
Not applicableStudy completedNCT03382392What this trial is testingHypermetabolism in ALS Using Six REE FormulasWho this might be right forAmyotrophic Lateral Sclerosis University Hospital, Limoges 449
Not applicableStudy completedNCT03411863What this trial is testingCervical Electrical Stimulation for ALSWho this might be right forAmyotrophic Lateral Sclerosis VA Office of Research and Development 19
Not applicableLooking for participantsNCT07091799What this trial is testingInterest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALSWho this might be right forAmyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders University Hospital, Bordeaux 50
Not applicableLooking for participantsNCT07726563What this trial is testingPlasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)Who this might be right forAmyotrophic Lateral Sclerosis (ALS)AutoantibodyPlasmapheresis National Taiwan University Hospital 20
Not applicableStudy completedNCT04440644What this trial is testingItalian Validation of the Beaumont Behavioural Inventory (BBI)Who this might be right forAmyotrophic Lateral Sclerosis Istituti Clinici Scientifici Maugeri SpA 190
Early research (Phase 1)Study completedNCT01424163What this trial is testingDexpramipexole Japanese PK StudyWho this might be right forAmyotrophic Lateral Sclerosis Knopp Biosciences 57
Early research (Phase 1)Looking for participantsNCT07401121What this trial is testingSafety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral SclerosisWho this might be right forALS (Amyotrophic Lateral Sclerosis) Celosia Therapeutics Pty Ltd 15
Early research (Phase 1)Active Not RecruitingNCT05633459What this trial is testingA Study Evaluating the Safety and Tolerability of QRL-201 in ALSWho this might be right forAmyotrophic Lateral Sclerosis QurAlis Corporation 69
Large-scale testing (Phase 3)Study completedNCT00035815What this trial is testingInsulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) TrialWho this might be right forAmyotrophic Lateral Sclerosis Mayo Clinic 330
Testing effectiveness (Phase 2)Ended earlyNCT01384162What this trial is testingAn Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral SclerosisWho this might be right forAmyotrophic Lateral Sclerosis Newron Sweden AB 15
Early research (Phase 1)Ended earlyNCT06453668What this trial is testingTCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) PatientsWho this might be right forALS ITB-Med LLC 7
Testing effectiveness (Phase 2)Study completedNCT00790582What this trial is testingA Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)Who this might be right forAmyotrophic Lateral Sclerosis Forbes Norris MDA/ALS Research Center 109